Rankings
▼
Calendar
ZBIO Q3 2025 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena
ZBIO
Zenas BioPharma, Inc.
$1B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$5M
Operating Income
-$53M
Net Income
-$51M
EPS (Diluted)
$-1.22
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$41M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$322M
Total Liabilities
$126M
Stockholders' Equity
$196M
Cash & Equivalents
$116M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$5M
-$34M
+85.1%
Operating Income
-$53M
-$41M
-28.3%
Net Income
-$51M
-$39M
-33.4%
← Q2 2025
All Quarters